NCT00169494 - Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 | Biotech Hunter

Enrollment

770

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL

HPV-16/18 L1/AS04

Trial Locations (17)

1162

GSK Investigational Site, Tallinn

2400

GSK Investigational Site, Koebenhavn NV

5000

GSK Investigational Site, Odense C

11527

GSK Investigational Site, Athens

11528

GSK Investigational Site, Athens

33200

GSK Investigational Site, Tampere

50417

GSK Investigational Site, Tartu

54642

GSK Investigational Site, Thessaloniki

60100

GSK Investigational Site, Seinäjoki

71110

GSK Investigational Site, Heraklion, Crete

119991

GSK Investigational Site, Moscow

214018

GSK Investigational Site, Smolensk

400130

GSK Investigational Site, Volgograd

420015

GSK Investigational Site, Kazan'

3011 EN

GSK Investigational Site, Rotterdam

3015 GE

GSK Investigational Site, Rotterdam

115 478

GSK Investigational Site, Moscow